Highlights from HIV Glasgow 2022: What Was New and Exciting?

Jürgen Rockstroh, MD
Head of Infectious Diseases
University Hospital Bonn
Bonn, Germany

Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc. Copyright © 2022. All rights reserved.



VIDEOTop of page

How to Obtain CME Credit:Top of page

Click here to take the CME Evaluation and Post-Meeting Survey

About the Presenters:Top of page

Dr. Jürgen Rockstroh, is Professor of Medicine and Head of the HIV Outpatient Clinic at the University of Bonn in Germany. He earned a Doctor of Medicine degree from the Rheinische Friedrich-Wilhelms University of Bonn, and completed his residency in the Department of Medicine also at the University of Bonn. His department treats the world’s largest cohort of HIV-infected hemophiliacs. In addition to his clinical practice, Dr. Rockstroh is involved in HIV research on: antiretroviral therapy, including new drug classes; the course of HIV disease in hemophiliacs; and HIV and hepatitis co-infection. More recently, he has also started working on the impact of COVID-19 on HIV-coinfection. He has been an investigator in multiple clinical trials of antiretroviral agents and treatments for HIV, hepatitis co-infection and COVID-19. Since 2009 he has been a member of the executive committee of the European AIDS Clinical Society (EACS).

Learning Objectives: Top of page

At the completion of this educational session, learners will:
1. Be up to date with the epidemiology, clinical presentations, and treatment options for monkeypox in Europe and be familiar with COVID-19 vaccine responses in PLWH and receive an update on recently completed COVID-19 treatment studies.
2. Understand the recent British HIV Association (BHIVA) and European AIDS Clinical Society (EACS) HIV treatment guideline updates and what has been changed around how and when to start antiviral therapy in PLWH.
3. Be aware of newly presented ART trials including long-term follow-up of the START trial, Gilead B/F/TAF registrational trials, TANGO and more recent data from long-acting therapies.
4. Learn about the characteristics and challenges of HIV management in Ukrainian war refugees in Europe.

CME Information:Top of page


This CME activity has approved for AMA PRA Category 1 Credit™ for December 14, 2022, as a live activity.  This activity will also be available as an enduring activity from December 15, 2022, through December 13, 2025.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

Accreditation Statement:Top of page


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement:Top of page

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:Top of page

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.

- Dr. James F. Braun (Course Director) has no relevant financial relationships to disclose.

- Dr. Joseph P. McGowan (Moderator) has no relevant financial relationships to disclose.

- Dr. Jürgen Rockstroh (Presenter)has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: DSMB Member with: Abivax, and Galapagos; Consultant to: Boehringer; Advisory Board Member to: Merck, Gilead, and ViiV; Speaker at: Merck, Gilead, ViiV, and Theratechnologies. Dr. Rockstroh submitted their slides in advance for adequate peer review and will support their presentation and clinical recommendations with the best available evidence from the medical literature. All relevant financial relationships have been mitigated.

Financial Support:Top of page

This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare

You must be logged in to post a comment. Login | Register